Does heparin rebound lead to postoperative blood loss in patients undergoing cardiac surgery with cardiopulmonary bypass?

• Published in: Perfusion 2024-11, Vol.39 (8), p.1491-1515
• Main Authors: Rijpkema, Marije, Vlot, Eline A, Stehouwer, Marco C, Bruins, Peter
• Format: Article
• Language: English
• Subjects: Bias; Blood; Blood coagulation; Blood transfusion; Bypass; Cardiac Surgical Procedures - adverse effects; Cardiac Surgical Procedures - methods; Cardiopulmonary Bypass - adverse effects; Cardiopulmonary Bypass - methods; Clinical trials; Coagulation; Heart; Heart surgery; Heparin; Heparin - adverse effects; Humans; Postoperative Hemorrhage - blood; Postoperative Hemorrhage - etiology; Protamine sulfate; Quality assessment; Quality control; Questions; Surgery; Viscoelasticity
• ISSN: 0267-6591; 1477-111X; 1477-111X
• DOI: 10.1177/02676591231199218

Background Heparin rebound is a common observed phenomenon after cardiac surgery with CPB and is associated with increased postoperative blood loss. However, the administration of extra protamine may lead to increased blood loss as well. Therefore, we want to investigate the relation between heparin rebound and postoperative blood loss and the necessity to provide extra protamine to reverse heparin rebound. Methods We searched PubMed, Cochrane, EMBASE, Google Scholar and Web of Science to review the question: “Does heparin rebound lead to postoperative blood loss in patients undergoing cardiac surgery with cardiopulmonary bypass.” Combination of search words were framed within four major categories: heparin rebound, blood loss, cardiac surgery and cardiopulmonary bypass. All studies that met our question were included. Quality assessment was performed using the Cochrane risk of bias (RoB2) tool for randomized controlled trials and the risk of bias in non-randomized studies of intervention (ROBINS-I) for non-randomised trials. Results 4 randomized and 17 non-randomized studies were included. The mean incidence of heparin rebound was 40%. The postoperative heparin levels, due to heparin rebound, were often below or equal to 0.2 IU/mL. We could not demonstrate an association between heparin rebound and postoperative blood loss or transfusion requirements. However the quality of evidence was poor due to a broad variety of definitions of heparin rebound, measured by various coagulation tests and studies with small sample sizes. Conclusion The influence of heparin rebound on postoperative bleeding seems to be negligible, but might get significant in conjunction with incomplete heparin reversal or other coagulopathies. For that reason, it might be useful to get a picture of the entire coagulation spectrum after cardiac surgery, as can be done by the use of a viscoelastic test in conjunction with an aggregometry test.